DUPIXENT

What this means for you

Registered since 14 Jun 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Jun 2036: the §8 & §9 renewal).

Record

Serial number

86807623

Registration number

4978127

Mark type

Word mark

Filed

03 Nov 2015

Published for opposition

29 Mar 2016

Registered

14 Jun 2016

Current term from

14 Jun 2026

Next maintenance filing

§8 & §9 renewal, due by 14 Jun 2036 (grace period to 14 Dec 2036)

Attorney of record

Alexandra Kochian

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders

Owner

• Sanofi Biotechnology, Paris, FR
• Sanofi Biotechnology, 75008 Paris, FR
• Sanofi Biotechnology, 75008 Paris, FR

Prosecution history

• 28 Jul 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 28 Jul 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 28 Jul 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 27 Jul 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 27 May 2026 — TEAS SECTION 8 & 9 RECEIVED
• 14 Jun 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 21 Nov 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
• 21 Nov 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
• 21 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 02 Jun 2022 — TEAS SECTION 8 RECEIVED
• 14 Jun 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
• 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
• 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE